We are live on ! Find out more
BHC

Bowen Hanes & Co Portfolio holdings

AUM $4.11B
1-Year Est. Return 44.45%
This Fund
S&P 500
This Quarter Est. Return
+2.04%
1 Year Est. Return
+44.45%
3 Year Est. Return
+134.49%
5 Year Est. Return
+186.16%
10 Year Est. Return
+747.69%
AUM
$2.07B
AUM Growth
+$10.9M
Cap. Flow
-$12.1M
Cap. Flow %
-0.58%
Top 10 Hldgs %
17.77%
Holding
135
New
9
Increased
39
Reduced
64
Closed
4

Top Sells

Rank Stock Value
1
LDOS icon
Leidos
LDOS
+$17.4M
2
GSK icon
GSK
GSK
+$14.5M
3
ERIC icon
Ericsson
ERIC
+$11.6M
4
CSCO icon
Cisco
CSCO
+$11M
5
DRC
DRESSER-RAND GROUP INC
DRC
+$9.89M

Sector Composition

Rank Sector Weight
1 Industrials 24.9%
2 Technology 14.69%
3 Consumer Staples 11.44%
4 Healthcare 10.68%
5 Materials 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAX icon
126
Baxter International
BAX
$12.2B
$202K 0.01%
+5,054
New +$189K
BAC icon
127
Bank of America
BAC
$405B
$187K 0.01%
10,900
-690
-6% -$11.6K
ABBV icon
128
AbbVie
ABBV
$464B
-4,250
Closed -$224K
ERIC icon
129
Ericsson
ERIC
$32.8B
-950,000
Closed -$11.6M
LDOS icon
130
Leidos
LDOS
$16.2B
-374,597
Closed -$17.4M
RIG icon
131
Transocean
RIG
$6.19B
-5,200
Closed -$257K

Similar funds

Bowen Hanes & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Bowen Hanes & Co held 135 positions worth $2.07B, up 0.53% from $2.06B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Bowen Hanes & Co's Q1 2014 filing shows 9 new, 39 increased, 64 reduced and 4 closed positions. Its largest new stake was Avery Dennison: 383,115 shares worth $19.4M. The largest sale was Leidos, an estimated $17.4M.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.

  • Bowen Hanes & Co's largest Q1 2014 buy was Avery Dennison: 383,115 shares worth $19.4M.
  • Bowen Hanes & Co added most to SUNEDISON, INC COM in Q1 2014, an estimated $14.3M increase.
  • Bowen Hanes & Co's biggest Q1 2014 reduction was GSK, cutting an estimated $14.5M.
  • Bowen Hanes & Co fully exited Leidos in Q1 2014, selling an estimated $17.4M.
  • Bowen Hanes & Co's ten largest holdings make up 18% of its $2.07B portfolio in Q1 2014.
  • Bowen Hanes & Co opened 9 new positions and closed 4 in Q1 2014.
  • Bowen Hanes & Co's portfolio value rose 0.53% quarter-over-quarter to $2.07B.

Based on Bowen Hanes & Co's 13F filing for Q1 2014, filed 15 May 2014.